Alopecia: FDA approves Olumiant for hair loss treatment
The Food and Drug Administration (FDA) originally approved Olumiant (baricitinib) in 2018 to treat rheumatoid arthritis.The a...
Anxiety in men: Fighting stereotypes
Anxiety disorders are among the most common mental health conditions worldwide. While they tend to affect women more than men, men are ...
Dementia and sleep: What do we know about this link?
Dementia affects at least 55 million people worldwide and the number is increasing by about 10 million every year. In part, this is bec...
Monkeypox outbreak: What to know
Since early May 2022, many countries in Europe, as well as Australia, and the U.S. have reported an increasing number of monkeypox case...
Oxford-AstraZeneca vaccine: What to know about side effects
Vaxzevria, the COVID-19 vaccine developed by the University of Oxford and AstraZeneca, may cause some of the mostly mild-to-moderate si...
Pfizer vaccine for COVID-19: What are the side effects?
The Pfizer-BioNTech COVID-19 vaccine may sometimes cause no side effects or mild-to-moderate side effects, which can be fairly common p...
Valneva COVID-19 vaccine: What do we know about it?
VLA2001, a new COVID-19 vaccine developed by Valneva, a French biotechnology company, using traditional methods, has now received condi...
Moderna says its Covid-19 vaccine performs as well in children as it does in adults
Moderna announced interim results of its Covid-19 vaccine for children younger than 6 on Wednesday.The company said two 25-microgram do...
Most people don’t know these possible signs of early Alzheimer’s
If you're not familiar with the term "mild cognitive impairment," you're not the only one. More than 80% of Americans aren't familiar w...
Early signs suggest the Omicron wave is peaking in some parts of the US, but relief is far from near
The Omicron surge has driven Covid-19 cases and hospitalizations to record highs in the United States. This week, however, officials ha...